Healthcare Industry News: CorPath
News Release - October 19, 2006
Corindus to Unveil CorPath(TM) its Remote Controlled Angioplasty System at TCT 2006
AUBURNDALE, Mass.--(HSMN NewsFeed)--Corindus, developer and marker of proprietary remote control catheterization systems, announced today that it will unveil CorPath(TM) in the emerging technologies area at the Cardiovascular Research Foundation's (CRF) eighteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.Corindus teamed up with Simbionix, a global leader in medical simulation technology, to offer live simulated cases using CorPath(TM). Tal Wenderow, Corindus' CEO, said "Physicians will have an opportunity to test CorPath(TM). Corindus will use Simbionix's latest medical angioplasty simulation system, the new ANGIO-Mentor(TM) mini, to allow physicians to experience angioplasty procedures using CorPath(TM)."
"CorPath(TM) allows physicians to perform endovascular procedures from a safe distance, diminishing their exposure to harmful X-ray radiation and the need to wear leaded garments," explained Wenderow. The CorPath(TM) system should help alleviate orthopedic injuries that are frequently reported from wearing leaded apparel. Wenderow said that one of the CorPath(TM) Investigators had to undergo cervical surgery this year after years of wearing leaded aprons. "Over time, the cumulative effects of radiation can be damaging, but so can years of wearing protective garments that can lead to neck and back problems."
Corindus will host CorPath(TM) simulated angioplasty cases from October 23rd through the 25th during morning and afternoon sessions. The live demonstrations will take place at Corindus' booth # 447. For more information on this unique opportunity visit Corindus on the web at http://corindus.com/news36.doc or email Corindus at TCT2006@corindus.com or by calling 617-581-6210.
About Corindus
Corindus designs, manufactures and commercializes patented remote control systems for interventional cardiology. Its CorPath(TM) system enables the physician to perform catheterization procedures from a remote location beyond the radiation zone. Compatible with state-of-the-art cardiology products and cath lab imaging technologies, CorPath(TM) mechanically maneuvers devices through patients' arteries as specified by the physician at a remote workstation. The proprietary technology utilizes physician fluoroscopic control similar to routine practice to allow maneuvering and torquing of cath lab devices. Initial clinical trials have demonstrated CorPath's safety and efficacy. Unique to CorPath(TM) is the simplicity of integration into existing cath lab systems.
The CorPath(TM) system requires regulatory clearance and currently is used for investigational purposes only.
Source: Corindus
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!